P&G Agrees to Sell Global Pharmaceuticals Business

The Procter & Gamble Co. announced yesterday it will sell its global pharmaceuticals business to Warner Chilcott plc., Ardee, Ireland, for $3.1 billion in cash.

CINCINNATI — The Procter & Gamble Co. here announced yesterday it will sell its global pharmaceuticals business to Warner Chilcott plc., Ardee, Ireland, for $3.1 billion in cash.

Under the terms of the agreement, Warner Chilcott, will acquire P&G's portfolio of branded pharmaceutical products, including Asacol HD (mesalamine) Delayed-Release Tablets for ulcerative colitis, Actonel (risedronate sodium) for osteoporosis, and the co-promotion rights to Enablex (darifenacin

Register to view the full article

Already a member? .